Bioerodible polymers for solid controlled release pharmaceutical compositions

• US 5,461,140 A
• Filed: 11/15/1993
• Issued: 10/24/1995
• Est. Priority Date: 04/30/1992
• Status: Expired due to Fees

• Current Assignee: Pharmaceutical Development Group
• Original Assignee: Pharmaceutical Development Group
• Inventors: Heller, Jorge, Ng, Steve Y. W.
• Primary Examiner(s): Seidleck, James J.
• Assistant Examiner(s): BOYKIN, TERRESSA M
• Application Number:
  US08/153,537
• Time in Patent Office: 708 Days
• Field of Search: 424/486, 424/423, 424/457, 514/179, 528/425, 568/831
• US Class Current: 528/425
• CPC Class Codes: A61K 9/204 Polyesters, e.g. poly(lactide-co-glycolide)
• CPC Class Codes: C08G 65/34 from hydroxy compounds or their metallic derivatives C08G65/26 takes precedence

Abstract

Bioerodible ortho ester polymers useful for preparing solid form bioerodible pharmaceutical compositions such as pellets, capsules, suppositories and the like are provided. A novel synthetic method for preparing the polymers is provided as well as is a novel triol reactant. Synthesis involves a one-step reaction between a monomeric ortho ester and a triol. The pharmaceutical compositions of the invention are useful for the controlled release of therapeutic agents, and may be administered for a variety of purposes.

Claims

1. A method for preparing a bioerodible polymer comprising:

reacting a monomeric ortho ester having the general formula ##STR11## wherein R is hydrogen or alkyl of 1 to 10 carbon atoms and R'"'"' is lower alkyl with a triol having the general formula ##STR12## wherein n is 1 to 5 carbon atoms, to form a rigid, bioerodible ortho ester polymer containing mer units of the structure ##STR13##

2. A compound of the formula ##STR14## wherein n is an integer in the range of 1 to 5 inclusive.

3. A composition comprising a polymer comprising mer units of the chemical formula ##STR15## wherein R is hydrogen or (C₁ -C₁₀)alkyl, and n is 1 to 5;

or co-polymers thereof or mixtures thereof.

4. The polymer of claim 3, having a molecular weight of at least about 5,000, as determined by gel permeation chromatography.

5. The polymer of claim 3, having a molecular weight of at least about 20,000, as determined by gel permeation chromatography.

6. The polymer of claim 3, having a molecular weight of at least about 50,000, as determined by gel permeation chromatography.

7. The polymer of claim 3, wherein n is 1.

8. The polymer of claim 3, wherein R is selected from the group consisting of CH₃, CH₂ CH₃ and CH₂ CH₂ CH₃.

9. The polymer of claim 3, wherein R is selected from the group consisting of CH₂ CH₂ CH₂ CH₃, CH₂ CH₂ CH₂ CH₂ CH₃ and CH₂ CH₂ CH₂ CH₂ CH₂ CH₃.

10. The polymer of claim 3, being a copolymer.

11. A bioerodible composition, comprising the composition of claim 3;

and an excipient.

12. The bioerodible composition of claim 11, wherein the excipient is selected from the group consisting of acidic and basic excipients.

13. The bioerodible composition of claim 11, further comprising an agent selected from the group consisting of colorants, diluents, odorants, carriers, excipients, stabilizers and skin permeation enhancers.

14. A solid, controlled release pharmaceutical composition comprising a therapeutic agent dispersed in the bioerodible composition of claim 11.

15. The solid, controlled release composition of claim 14, in the form of a suppository, pellet or capsule.

16. The solid, controlled release composition of claim 14, wherein the therapeutic agent is present in an amount of about 0.001 to 70wt. % of the composition.

17. The solid, controlled release composition of claim 14, wherein the therapeutic agent is selected from the group consisting of anti-infective, analgesic, antihelminthic, anti-arthritic, anti-asthmatic, anti-convulsant, anti-depressant, anti-diabetic, anti-diarrheal, anti-histamine, anti-inflammatory, anti-migraine, anti-nauseant, antineoplastic, anti-parkinsonism, anti-pruritic, anti-psychotic, anti-pyretic, anti-spasmodic, anti-cholinergic, sympathomimetic, cardiovascular, anti-hypertensive, diuretic, and vasodilator agents, xanthine derivatives, central nervous system stimulants, cough and cold preparations, hormones, hypnotics, immunosuppressives, muscle relaxants, parasympatholytics, psychostimulants, sedatives, and tranquilizers.

18. The solid, slow release composition of claim 13, wherein the therapeutic agent is selected from the group consisting of steroid, anti-hypertensive, anti-allergic and thyroid affecting agents.

19. A controlled release method of delivering a pharmaceutical agent, comprising

administering to a subject the solid pharmaceutical composition of claim 14;

and

allowing the composition to release, in a controlled manner, an effective amount of the pharmaceutical agent while the polymer is bioeroded and physiologically eliminated by the subject.

20. The controlled release method of claim 19, wherein the solid composition is administered subcutaneously, intramuscularly or enterically.

21. The controlled release method of claim 19, wherein the solid composition is administered locally.

22. The controlled release method of claim 21, wherein the local admininstration is conducted by implantation or insertion of the solid composition proximate to a desired target tissue.

23. A method for preparing a bioerodible polymer, comprising contacting at least one monomeric ortho ester of the chemical formula ##STR16## wherein R is hydrogen or (C₁ -C₁₀)alkyl, and R'"'"' is (C₁ -C₅)alkyl, with at least one triol of the chemical formula ##STR17## wherein n is 1 to 5, under conditions effective to form a bioerodible ortho ester polymer comprising mer units of the chemical formula ##STR18##

24. The method of claim 23, wherein the number of mer units in the polymer is about 2 to 1000.

25. The method of claim 24, wherein the number of mer units in the polymer is about 2 to 200.

26. The method of claim 25, wherein the number of mer units in the polymer is about 5 to 200.

27. The method of claim 23, wherein

the monomeric ortho ester is reacted with more than one triol;

and

the bioerodible ortho ester polymer is a co-polymer.

28. A bioerodible polymer of the chemical formula ##STR19## wherein R is hydrogen, and n is 1 to 5;

or co-polymers thereof or mixtures thereof, prepared by the method of claim 23.